Compare DDS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DDS | ICLR |
|---|---|---|
| Founded | 1938 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 9.3B |
| IPO Year | N/A | 2001 |
| Metric | DDS | ICLR |
|---|---|---|
| Price | $610.01 | $146.18 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $519.67 | $178.62 |
| AVG Volume (30 Days) | 111.1K | ★ 1.1M |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.99 | N/A |
| Revenue Next Year | $1.09 | N/A |
| P/E Ratio | $18.08 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $396.99 | $66.57 |
| 52 Week High | $741.98 | $211.00 |
| Indicator | DDS | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 57.71 | 63.32 |
| Support Level | $601.54 | $99.11 |
| Resistance Level | $635.05 | $188.03 |
| Average True Range (ATR) | 21.52 | 8.29 |
| MACD | 2.71 | 1.04 |
| Stochastic Oscillator | 73.52 | 77.73 |
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.